Chief Science Officer · Century Therapeutics, Inc. (IPSC)

Luis Borges

A named executive officer of Century Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,272,526

Salary $427,698Stock awards $0

FY2020: $545,000

3rd of 3 named executive officers at Century Therapeutics by FY2021 total.

3 named officers on file for Century Therapeutics, FY2021

Luis Borges’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Century Therapeutics’s whole pay program stands against its peers

  • Century Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IPSC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Luis Borges’s full pay file as a PDF — free

More than this page: up to 10 years of Luis’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Luis Borges compensation by year

Century Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Century Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$410,000$427,698
Bonus$0$0
Stock awards$0$0
Option awards$0$668,410
Non-equity incentive$123,600$164,818
Pension and deferred compensation$0$0
All other$11,400$11,600
Total$545,000$1,272,526

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Century Therapeutics, Inc. DEF 14A filed April 21, 2022, accession 0001104659-22-048376, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Century Therapeutics, Inc. filed document, accession 0001104659-22-048376. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2022.

$545K
$1.3M
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option119,232—$1.03
Option146,826—$7.27

Per the Outstanding Equity Awards at Fiscal Year-End table in Century Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

15 Form 4 lines since the FY2021 proxy (filed April 21, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-04-03Exercise or conversion—7,452$1.03256,535
2023-04-03Exercise or conversion derivative—7,452$0.000
2023-03-23Exercise or conversion derivative—220,930$0.007,452
2023-03-23Exercise or conversion—220,930$1.03264,680
2023-03-23Sale—15,597$3.55249,083
2023-03-22Exercise or conversion—65,698$1.03109,448
2023-03-22Sale—65,698$3.7243,750
2023-03-22Exercise or conversion derivative—65,698$0.00228,382

The 8 most recent of 15 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Century Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Osvaldo FloresPresident and Chief Executive Officer$4,317,168
Adrienne FaridChief Operations Officer$1,534,766
Luis Borges · this pageChief Science Officer$1,272,526

The full Century Therapeutics compensation record

free company brief

This page is one person within Century Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Century Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Luis Borges's compensation dossier · One-time report. No refunds.